Literature DB >> 7539102

Wild-type human p53 and a temperature-sensitive mutant induce Fas/APO-1 expression.

L B Owen-Schaub1, W Zhang, J C Cusack, L S Angelo, S M Santee, T Fujiwara, J A Roth, A B Deisseroth, W W Zhang, E Kruzel.   

Abstract

Fas/APO-1 is a cell surface protein known to trigger apoptosis upon specific antibody engagement. Because wild-type p53 can activate transcription as well as induce apoptosis, we queried whether p53 might upregulate Fas/APO-1. To explore this possibility, we examined human p53-null (H358 non-small-cell lung adenocarcinoma and K562 erythroleukemia) and wild-type p53-containing (H460 non-small-cell lung adenocarcinoma) cell lines. When H358 or H460 cells were transduced with a replication-deficient adenovirus expression construct containing the human wild-type p53 gene but not with vector alone, a marked upregulation (approximately a three-to fourfold increase) of cell surface Fas/APO-1 was observed by flow cytometry. Similarly, K562, cells stably transfected with a plasmid vector containing the temperature-sensitive human p53 mutant Ala-143 demonstrated a four- to sixfold upregulation of Fas/APO-1 by flow-cytometric analysis at the permissive temperature of 32.5 degrees C. Temperature-sensitive upregulation of Fas/APO-1 in K562 Ala-143 cells was verified by immunoprecipitation and demonstrated to result from enhanced mRNA production by nuclear run-on and Northern (RNA) analyses. Stably transfected K562 cells expressing temperature-insensitive, transcriptionally inactive p53 mutants (His-175, Trp-248, His-273, or Gly-281) failed to upregulate Fas/APO-1 at either 32.5 degrees or 37.5 degrees C. The temperature-sensitive transcription of Fas/APO-1 occurred in the presence of cycloheximide, indicating that de novo protein synthesis was not required and suggested a direct involvement of p53. Collectively, these observations argue that Fas/APO-1 is a target gene for transcriptional activation by p53.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7539102      PMCID: PMC230534          DOI: 10.1128/MCB.15.6.3032

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  83 in total

Review 1.  The apoptosis endonuclease and its regulation.

Authors:  A H Wyllie; M J Arends; R G Morris; S W Walker; G Evan
Journal:  Semin Immunol       Date:  1992-12       Impact factor: 11.130

2.  Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53.

Authors:  L R Livingstone; A White; J Sprouse; E Livanos; T Jacks; T D Tlsty
Journal:  Cell       Date:  1992-09-18       Impact factor: 41.582

3.  Cell cycle analysis of p53-induced cell death in murine erythroleukemia cells.

Authors:  J J Ryan; R Danish; C A Gottlieb; M F Clarke
Journal:  Mol Cell Biol       Date:  1993-01       Impact factor: 4.272

4.  Aberrant transcription caused by the insertion of an early transposable element in an intron of the Fas antigen gene of lpr mice.

Authors:  M Adachi; R Watanabe-Fukunaga; S Nagata
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-01       Impact factor: 11.205

5.  Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles.

Authors:  Y Yin; M A Tainsky; F Z Bischoff; L C Strong; G M Wahl
Journal:  Cell       Date:  1992-09-18       Impact factor: 41.582

6.  Growth suppression of Friend virus-transformed erythroleukemia cells by p53 protein is accompanied by hemoglobin production and is sensitive to erythropoietin.

Authors:  P Johnson; S Chung; S Benchimol
Journal:  Mol Cell Biol       Date:  1993-03       Impact factor: 4.272

7.  A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia.

Authors:  M B Kastan; Q Zhan; W S el-Deiry; F Carrier; T Jacks; W V Walsh; B S Plunkett; B Vogelstein; A J Fornace
Journal:  Cell       Date:  1992-11-13       Impact factor: 41.582

8.  Regulation of the human hsp70 promoter by p53.

Authors:  S N Agoff; J Hou; D I Linzer; B Wu
Journal:  Science       Date:  1993-01-01       Impact factor: 47.728

9.  mdm2 expression is induced by wild type p53 activity.

Authors:  Y Barak; T Juven; R Haffner; M Oren
Journal:  EMBO J       Date:  1993-02       Impact factor: 11.598

10.  Fas involvement in Ca(2+)-independent T cell-mediated cytotoxicity.

Authors:  E Rouvier; M F Luciani; P Golstein
Journal:  J Exp Med       Date:  1993-01-01       Impact factor: 14.307

View more
  128 in total

Review 1.  The complexity of radiation stress responses: analysis by informatics and functional genomics approaches.

Authors:  A J Fornace; S A Amundson; M Bittner; T G Myers; P Meltzer; J N Weinsten; J Trent
Journal:  Gene Expr       Date:  1999

Review 2.  Death and destruction of activated T lymphocytes.

Authors:  I N Crispe
Journal:  Immunol Res       Date:  1999       Impact factor: 2.829

Review 3.  Dial 9-1-1 for p53: mechanisms of p53 activation by cellular stress.

Authors:  M Ljungman
Journal:  Neoplasia       Date:  2000 May-Jun       Impact factor: 5.715

4.  The tumor suppressor p53 can both stimulate and inhibit ultraviolet light-induced apoptosis.

Authors:  B C McKay; F Chen; C R Perumalswami; F Zhang; M Ljungman
Journal:  Mol Biol Cell       Date:  2000-08       Impact factor: 4.138

5.  p53 Gene therapy for lung cancer.

Authors:  Stephen G Swisher; Jack A Roth
Journal:  Curr Oncol Rep       Date:  2002-07       Impact factor: 5.075

6.  Hydrogen peroxide-induced apoptosis in human hepatoma cells is mediated by CD95(APO-1/Fas) receptor/ligand system and may involve activation of wild-type p53.

Authors:  C Huang; J Li; R Zheng; K Cui
Journal:  Mol Biol Rep       Date:  2000-03       Impact factor: 2.316

7.  The K-bZIP protein from Kaposi's sarcoma-associated herpesvirus interacts with p53 and represses its transcriptional activity.

Authors:  J Park; T Seo; S Hwang; D Lee; Y Gwack; J Choe
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

8.  The p53 status in juvenile chronic arthritis and rheumatoid arthritis.

Authors:  H Taubert; B Thamm; A Meye; F Bartel; A K Rost; D Heidenreich; V John; J Brandt; M Bache; P Würl; H Schmidt; D Riemann
Journal:  Clin Exp Immunol       Date:  2000-11       Impact factor: 4.330

Review 9.  Immune surveillance in melanoma: From immune attack to melanoma escape and even counterattack.

Authors:  Fade Mahmoud; Bradley Shields; Issam Makhoul; Nathan Avaritt; Henry K Wong; Laura F Hutchins; Sara Shalin; Alan J Tackett
Journal:  Cancer Biol Ther       Date:  2017-05-17       Impact factor: 4.742

10.  Methylation of RASSF1A gene promoter is regulated by p53 and DAXX.

Authors:  Hailong Zhang; Jing He; Jiansha Li; Dan Tian; Lubing Gu; Muxiang Zhou
Journal:  FASEB J       Date:  2012-10-04       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.